Protocol for autofluorescence-driven isolation of human peripheral blood eosinophils Authors: Tobias Weihrauch, Natalie Gray, N. Helge Meyer, Karin Loser, Ulrike Raap Published: 2024 ABSTRACT SummaryMost common techniques for isolating eosinophils utilize CD16-negative selection, neglecting the CD16-positive fraction of eosinophils. Here, we present a protocol for isolating human CD16+ and CD16− eosinophils based on their autofluorescence using the MACSQuant Tyto cell sorter. We describe steps for purifying eosinophils and assessing purity, viability, and functional activity. We then detail procedures for Giemsa staining and the assessment of CD16 expression on human eosinophils. This protocol yields eosinophil purities of over 99%. Before you begin For investigating eosinophils, the cells are usually isolated from peripheral blood with methods such as immunomagnetic selection or density gradient centrifugation. However, these techniques, especially density gradient centrifugation, have the potential of resulting in lower yields or viability.1 In the case of immunomagnetic selection these parameters may also be influenced as a result of manufacturer specific isolation kit composition and the mode of immunomagnetic selection.2 In addition, negative immunomagnetic selection of eosinophils commonly excludes CD16+ (FcγRIII) eosinophils, though this minor cell population is implicated in health and disease. For allergic conditions such as allergic rhinosinusitis or asthma, increased CD16 expression on eosinophils has been described when compared to eosinophils of non-atopic patients.3 Given that eosinophils are a relatively rare type of leukocyte, and experiments usually require hundreds of thousands of cells, it is crucial to isolate them as effectively and gently as possible from patients’ blood. In comparison to other leukocytes, eosinophils show a marked autofluorescence with an emission wavelength of ∼520 nm and local excitation maxima of ∼380 nm and ∼450 nm. This autofluorescence is caused by flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and riboflavin in eosinophil granules.4 Based on this unique characteristic, eosinophils can be isolated from other leukocytes using a completely label-free method, without relying on techniques that include antibodies, such as negative immunomagnetic selection. This protocol presents a highly effective and cell-friendly method for autofluorescence-dependent isolation of eosinophils, including CD16+ eosinophils, from venous blood foregoing the necessity of antibodies or beads. The isolation of eosinophils is performed using the MACSQuant Tyto cell sorter. We consistently get a high purity of > 99% and an average viability of 93% with this time-efficient method. Therefore, we further describe the procedures of determining these percentages in addition to visualizing the purity by Giemsa staining. In order to assess CD16− and CD16+ eosinophil populations, we provide a CD16 staining protocol. To show that the eosinophils are not pre-activated and cell activation is still inducible after sorting we performed an eosinophil activation test. We used some of the supporting methods recently for investigating TRPV1 (Transient Receptor Potential Vanilloid 1) on human eosinophils.5 However, this isolation technique can be used for any subsequent experiments with human eosinophils, especially when investigating differences between health and disease due to the inclusion of CD16+ eosinophils. Institutional permissions The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Carl von Ossietzky University Oldenburg (protocol code 2021–025) for studies involving humans. Patient materials were collected by the Department of Dermatology and Allergy of Human Medicine at the Klinikum Oldenburg. Before performing the following protocol with blood samples, make sure to get an approval by your local ethics committee. Biosafety The work with potentially infectious material such as human blood or purified cells requires proper biosafety practices. We recommend wearing personal protective equipment such as lab coat, gloves, and eye protection, and using filter tips for pipettes. The conscientious decontamination of all reagents and surfaces after finishing the experiments is essential. We recommend autoclaving all waste products and using commercial aldehyde-free decontamination solutions (e.g., Inciding Plus or Lerasept), according to the manufacturer’s instructions, to decontaminate surfaces. Collection of blood samples Timing: 10 min 1.Obtain blood by drawing blood via venipuncture into monovettes that have been preloaded with the appropriate amount of Ethylenediaminetetraacetic acid (EDTA) to obtain a final concentration of 1.6 mg EDTA per mL of blood.a.Pull back the plunger gently to minimize force that could potentially damage the cells.b.Invert the monovettes five times carefully to ensure the blood mixes well with the EDTA. Timing: 10 min 1.Obtain blood by drawing blood via venipuncture into monovettes that have been preloaded with the appropriate amount of Ethylenediaminetetraacetic acid (EDTA) to obtain a final concentration of 1.6 mg EDTA per mL of blood.a.Pull back the plunger gently to minimize force that could potentially damage the cells.b.Invert the monovettes five times carefully to ensure the blood mixes well with the EDTA. Obtain blood by drawing blood via venipuncture into monovettes that have been preloaded with the appropriate amount of Ethylenediaminetetraacetic acid (EDTA) to obtain a final concentration of 1.6 mg EDTA per mL of blood.a.Pull back the plunger gently to minimize force that could potentially damage the cells.b.Invert the monovettes five times carefully to ensure the blood mixes well with the EDTA. a.Pull back the plunger gently to minimize force that could potentially damage the cells. Pull back the plunger gently to minimize force that could potentially damage the cells. b.Invert the monovettes five times carefully to ensure the blood mixes well with the EDTA. Invert the monovettes five times carefully to ensure the blood mixes well with the EDTA. Preparation of devices and reagents Timing: 30 min 2.Start and initialize all devices and precool the centrifuges and MACSQuant Tyto to 4°C.3.Prepare the reagents as listed in materials and equipment. Timing: 30 min 2.Start and initialize all devices and precool the centrifuges and MACSQuant Tyto to 4°C. Start and initialize all devices and precool the centrifuges and MACSQuant Tyto to 4°C. 3.Prepare the reagents as listed in materials and equipment. Prepare the reagents as listed in materials and equipment. Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesAPC anti-human CD69 antibody (undiluted)Miltenyi BiotecCat# 130-112-614;Clone: REA824APC-A750 anti-human CD16 antibody (undiluted)Beckman CoulterCat# B49184;Clone: 3G8PE-Cyanin 7 (PC7) anti-human Siglec-8 antibody (undiluted)BioLegendCat# 347112;Clone: 7C9RRID: AB_2629720Biological samplesHuman venous blood, freshly drawnKlinikum OldenburgN/AChemicals, peptides, and recombinant proteins7-AAD staining solutionMiltenyi BiotecCat# 130-11-568Albumin bovine serum (BSA)VWRCat# 421501JBuffer tablets pH 7.2MerckCat# 1.09468.0100Giemsa’s azure eosin methylene blue solutionMerckCat# 1.09204.2500IL-3PeproTechCat# 200-03-2UGMACS Quant Tyto running bufferMiltenyi BiotecCat# 130-107-207MethanolITW ReagentsCat# 221091Neo-Mount mounting mediumMerckCat# 1.09016.0500Penicillin-StreptomycinGibcoCat# 15140122Phosphate-buffered saline (PBS)RothCat# 9143.2RBC Lysis bufferBioLegendCat# 420302RPMI 1640 mediumVWRCat# 392–0426Software and algorithmsKaluza 2.1.1Beckman CoulterN/AOther1.5 mL microcentrifuge tubesSarstedtCat# 72.690.00150 mL polypropylene (PP) conical tubesSarstedtCat# 62.547.2549 mL EDTA K3E preloaded monovettesSarstedtCat# 02.1066.001Adhesive microscopy slidesMarienfeld SuperiorCat# 0810001Cover slips, 18 mm × 18 mmVWRCat# 631–1567Cytoflex SBeckman CoulterN/ADisposable syringe (10 mL)RothCat# EP97.1Epredia TPX single sample chamberFisher ScientificCat# A78710018Filter cardsFisher ScientificCat# 5991022Fisherbrand Gel-loading tips, 1–200 μLFisher ScientificCat# 11367801Galaxy 170S CO2 incubatorEppendorfN/AGlass staining troughEngelbrechtCat# 42460Hydrophobic barrier penMerckCat# Z377821-1EAMACSQuant Tyto CartridgeMiltenyi BiotecCat# 130-104-791MACSQuant Tyto Priming FixtureMiltenyi BiotecCat# 130-119-832MACSQuant TytoMiltenyi BiotecN/AMicrocentrifuge 5425REppendorfN/AMyBlock Mini Dry Bath heat blockBenchmark ScientificCat# BSH200-HLOlympus BX51 MicroscopeOlympusN/APipette tips (10 μL)BiozymCat# VT0290Pipette tips (200 μL)BiozymCat# VT0240Pipette tips (1250 μL)BiozymCat# VT0270Pre-separation filters (20 μm)Miltenyi BiotecCat# 130-101-812Research Plus pipette (0.5–10 μL)EppendorfCat# 3123000020Research Plus pipette (10–100 μL)EppendorfCat# 3123000047Research Plus pipette (100–1000 μL)EppendorfCat# 3123000063Shandon Cytoclip stainless steel slide clipFisher ScientificCat# 12608036Shandon Cytospin 4 cytocentrifugeFisher ScientificCat# A78300003Tabletop centrifuge 5810REppendorfN/AVornado Mini Vortex MixerBenchmark ScientificCat# BV101-B REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesAPC anti-human CD69 antibody (undiluted)Miltenyi BiotecCat# 130-112-614;Clone: REA824APC-A750 anti-human CD16 antibody (undiluted)Beckman CoulterCat# B49184;Clone: 3G8PE-Cyanin 7 (PC7) anti-human Siglec-8 antibody (undiluted)BioLegendCat# 347112;Clone: 7C9RRID: AB_2629720Biological samplesHuman venous blood, freshly drawnKlinikum OldenburgN/AChemicals, peptides, and recombinant proteins7-AAD staining solutionMiltenyi BiotecCat# 130-11-568Albumin bovine serum (BSA)VWRCat# 421501JBuffer tablets pH 7.2MerckCat# 1.09468.0100Giemsa’s azure eosin methylene blue solutionMerckCat# 1.09204.2500IL-3PeproTechCat# 200-03-2UGMACS Quant Tyto running bufferMiltenyi BiotecCat# 130-107-207MethanolITW ReagentsCat# 221091Neo-Mount mounting mediumMerckCat# 1.09016.0500Penicillin-StreptomycinGibcoCat# 15140122Phosphate-buffered saline (PBS)RothCat# 9143.2RBC Lysis bufferBioLegendCat# 420302RPMI 1640 mediumVWRCat# 392–0426Software and algorithmsKaluza 2.1.1Beckman CoulterN/AOther1.5 mL microcentrifuge tubesSarstedtCat# 72.690.00150 mL polypropylene (PP) conical tubesSarstedtCat# 62.547.2549 mL EDTA K3E preloaded monovettesSarstedtCat# 02.1066.001Adhesive microscopy slidesMarienfeld SuperiorCat# 0810001Cover slips, 18 mm × 18 mmVWRCat# 631–1567Cytoflex SBeckman CoulterN/ADisposable syringe (10 mL)RothCat# EP97.1Epredia TPX single sample chamberFisher ScientificCat# A78710018Filter cardsFisher ScientificCat# 5991022Fisherbrand Gel-loading tips, 1–200 μLFisher ScientificCat# 11367801Galaxy 170S CO2 incubatorEppendorfN/AGlass staining troughEngelbrechtCat# 42460Hydrophobic barrier penMerckCat# Z377821-1EAMACSQuant Tyto CartridgeMiltenyi BiotecCat# 130-104-791MACSQuant Tyto Priming FixtureMiltenyi BiotecCat# 130-119-832MACSQuant TytoMiltenyi BiotecN/AMicrocentrifuge 5425REppendorfN/AMyBlock Mini Dry Bath heat blockBenchmark ScientificCat# BSH200-HLOlympus BX51 MicroscopeOlympusN/APipette tips (10 μL)BiozymCat# VT0290Pipette tips (200 μL)BiozymCat# VT0240Pipette tips (1250 μL)BiozymCat# VT0270Pre-separation filters (20 μm)Miltenyi BiotecCat# 130-101-812Research Plus pipette (0.5–10 μL)EppendorfCat# 3123000020Research Plus pipette (10–100 μL)EppendorfCat# 3123000047Research Plus pipette (100–1000 μL)EppendorfCat# 3123000063Shandon Cytoclip stainless steel slide clipFisher ScientificCat# 12608036Shandon Cytospin 4 cytocentrifugeFisher ScientificCat# A78300003Tabletop centrifuge 5810REppendorfN/AVornado Mini Vortex MixerBenchmark ScientificCat# BV101-B Materials and equipment Lysis bufferReagentFinal concentrationAmountRBC Lysis buffer 10x1x100 mLddH2ON/A900 mLTotalN/A1000 mLStore at 4°C for up to 3 months. Lysis bufferReagentFinal concentrationAmountRBC Lysis buffer 10x1x100 mLddH2ON/A900 mLTotalN/A1000 mLStore at 4°C for up to 3 months. Lysis buffer Store at 4°C for up to 3 months. PBS + 1% BSA Dissolve 2 g purified BSA in 20 mL ultrapure water or 1X PBS to obtain a 10% BSA stock solution by mixing in a 50 mL conical tube. Dilute 5 mL of 10% BSA with 45 mL 1X PBS. Staining buffer Dissolve one buffer tablet (pH 7.2) in 1 L ultrapure water on a magnetic stirrer. Store at 4°C for up to 3 months.Giemsa staining solutionReagentFinal concentrationAmountGiemsa’s azure eosin methylene blue solution1:201 mLStaining bufferN/A19 mLTotalN/A20 mLPrepare freshly and wait 10 min before usage. Giemsa staining solutionReagentFinal concentrationAmountGiemsa’s azure eosin methylene blue solution1:201 mLStaining bufferN/A19 mLTotalN/A20 mLPrepare freshly and wait 10 min before usage. Giemsa staining solution Prepare freshly and wait 10 min before usage. Step-by-step method details Isolation of human eosinophils via autofluorescence Timing: 2 h Timing: 2 h This protocol outlines a reliable method for isolating eosinophils from whole human blood with the MACSQuant Tyto Cell Sorter, using their autofluorescence signal. However, this procedure can be adapted for use with any other cell sorter that is equipped with a violet laser and utilizes the same or similar wavelength detection channels. For specific details, refer to the instruction manual of your cell sorter.1.Red Blood Cell Lysis.a.Transfer 3–5 mL of EDTA blood into a 50 mL conical tube, fill up to 50 mL with lysis buffer and vortex the cell suspension for 5 s.b.Incubate at 19°C–22°C for 7 min.c.Centrifuge the cell suspension at 300 × g for 10 min at 4°C.d.Decant and discard the supernatant.CRITICAL: No supernatant should remain in the conical tube, since any debris and dilution of cells prolongs the duration of the eosinophil sorting procedure and raises the sorting volume.e.Resuspend the cell pellet in 1 mL PBS + 1% BSA and place the cell suspension on ice.2.Predetermination of eosinophil cell count and rate.a.Dilute 10 μL of cell suspension with 40 μL PBS.b.On a Beckman Cytoflex S, eosinophil autofluorescence is best detected at 405/450 nm and 405/525 nm, e.g., corresponding to the PB450/VioBlue or KO525/VioGreen channels. Set the eosinophil autofluorescence gate according to Figure 1.Figure 1Determining eosinophil percentage after the lysis stepRepresentative dot plot showing unsorted cells after the lysis step on eosinophil autofluorescence-specific wave lengths of 405/450 nm and 405/525 nm. The gate for eosinophils was set on according to the positively separated cell population. Percentage and total cell count were used for the calculation of dilution with MACSQuant Tyto Running Buffer.CRITICAL: We used a Cytoflex S (Beckman Coulter) flow cytometer for cell counting. When using other flow cytometry devices, please check the specific settings and use equivalent channels or channels detecting similar wave lengths.3.Loading cells into the sorting chamber.a.To prime the cartridge, place it on the MACS Quant Tyto Priming Fixture by aligning the feet with the slots in the base (Figure 2).Figure 2Set-up for cartridge primingThe cartridge is placed on the dark green magnetic priming fixture in order to open the sort valve. A Syringe is screwed onto the input chamber. A Pre-Separation Filter (20 μm; green) is used for the following addition of the cell suspension.b.Open the intake of the input chamber (chamber with the depiction of an owl).c.Attach a syringe of which the plunger has been removed, onto it (Figure 2).d.Add 300 μL PBS + 1% BSA into the syringe.e.Insert the plunger and slowly and carefully push it down until PBS becomes visible in the positive collection chamber (middle chamber) and stop immediately. Troubleshooting 1.f.Remove the cartridge from the MACS Quant Tyto Priming Fixture and close the pressure inlet with the O-ring, which is located at the right corner underneath the cartridge, using your thumb.g.Continue pressing the plunger down until PBS becomes visible in the negative collection chamber. Stop immediately and remove the syringe.CRITICAL: Do not touch the microchip underneath the cartridge at any time. Troubleshooting 2.h.Place the cartridge in its plastic packaging on ice and remove the syringe.i.Dilute the 1 mL cell suspension in the appropriate calculated amount of Tyto Running Buffer and mix gently.CRITICAL: Adjust the cell concentration to a maximum of 2.1 × 106 total cells per mL sorting volume with an eosinophil rate between 0.8% and 8.2%.CRITICAL: Be aware of the maximum sorting volume of 10 mL per sort. A higher volume and dilution of the cell suspension will result in a longer duration of sort but also in higher purities. The maximum predicted eosinophil count must not exceed 1 × 106 cells/mL in the final sorting volume.j.Attach a syringe without the plunger onto the intake of the input chamber, place a green 20 μm pre-separation filter (Figure 2) on the syringe and filter the entire cell suspension.Note: If the cell suspension does not flow through the filter automatically, place a thumb flat on the intake of the filter and apply some air pressure onto the filter without touching the cell suspension. Alternatively, the filter can be moisturized with Tyto running buffer before usage.k.Remove the pre-separation filter, carefully insert the plunger into the syringe, and transfer the cell suspension into the input chamber.l.Remove the syringe and close the intake of the input chamber.4.Eosinophil sort on MACSQuant Tyto.a.Scan the 2D barcode of the cartridge at the front of the MACS Quant Tyto Cell Sorter.b.Open the lid of the instrument and insert the cartridge in the correct orientation (with the input chamber facing the user and front of the instrument). The cartridge is placed correctly if the propeller in the input chamber starts spinning.c.In the user interface, select the cartridge type and enter the sample name and total sorting volume.d.Configure the live dot plot by selecting the channels CFP/VioBlue-H on the Y-axis and VioGreen-H on the X-axis.e.Start the cell flow in the cartridge by clicking the Play button in the lower right corner.f.Set a gate on the separated eosinophils population according to Figure 3 and select this gate as the sorting gate.Figure 3Eosinophil sorting using the MACSQuant Tyto Cell SorterRepresentative dot plot of eosinophil sorting with sort gate (P1) on the eosinophil population.g.Start sorting by pressing the Sort button in the lower right corner.CRITICAL: An abortion rate below 1% will result in a high yield and purity. If the abortion rate is higher, verify the purity of sorted eosinophils in order to ensure precise and effective sorting. If eosinophil purity and yield are inadequate, further dilute the cell suspension in the input chamber with Tyto running buffer.h.Stop the sort once all cells have been sorted or the desired number of sorted eosinophils has been acquired. Troubleshooting 3.i.Open the sort chamber and transfer the sorted eosinophils to a 1.5 mL microcentrifuge tube with a gel-loading tip.CRITICAL: Measure the exact volume with the pipette for subsequent calculations of eosinophil concentrations.j.Remove any remaining eosinophils from the sort chamber by washing it with 100 μL PBS. Collect the washing solution in the microcentrifuge tube and repeat this washing step twice. Keep eosinophils on ice.k.The eosinophils are now ready to be used in further experiments. 1.Red Blood Cell Lysis.a.Transfer 3–5 mL of EDTA blood into a 50 mL conical tube, fill up to 50 mL with lysis buffer and vortex the cell suspension for 5 s.b.Incubate at 19°C–22°C for 7 min.c.Centrifuge the cell suspension at 300 × g for 10 min at 4°C.d.Decant and discard the supernatant.CRITICAL: No supernatant should remain in the conical tube, since any debris and dilution of cells prolongs the duration of the eosinophil sorting procedure and raises the sorting volume.e.Resuspend the cell pellet in 1 mL PBS + 1% BSA and place the cell suspension on ice. Red Blood Cell Lysis.a.Transfer 3–5 mL of EDTA blood into a 50 mL conical tube, fill up to 50 mL with lysis buffer and vortex the cell suspension for 5 s.b.Incubate at 19°C–22°C for 7 min.c.Centrifuge the cell suspension at 300 × g for 10 min at 4°C.d.Decant and discard the supernatant.CRITICAL: No supernatant should remain in the conical tube, since any debris and dilution of cells prolongs the duration of the eosinophil sorting procedure and raises the sorting volume.e.Resuspend the cell pellet in 1 mL PBS + 1% BSA and place the cell suspension on ice. a.Transfer 3–5 mL of EDTA blood into a 50 mL conical tube, fill up to 50 mL with lysis buffer and vortex the cell suspension for 5 s. Transfer 3–5 mL of EDTA blood into a 50 mL conical tube, fill up to 50 mL with lysis buffer and vortex the cell suspension for 5 s. b.Incubate at 19°C–22°C for 7 min. Incubate at 19°C–22°C for 7 min. c.Centrifuge the cell suspension at 300 × g for 10 min at 4°C. Centrifuge the cell suspension at 300 × g for 10 min at 4°C. d.Decant and discard the supernatant.CRITICAL: No supernatant should remain in the conical tube, since any debris and dilution of cells prolongs the duration of the eosinophil sorting procedure and raises the sorting volume. Decant and discard the supernatant.CRITICAL: No supernatant should remain in the conical tube, since any debris and dilution of cells prolongs the duration of the eosinophil sorting procedure and raises the sorting volume. CRITICAL: No supernatant should remain in the conical tube, since any debris and dilution of cells prolongs the duration of the eosinophil sorting procedure and raises the sorting volume. e.Resuspend the cell pellet in 1 mL PBS + 1% BSA and place the cell suspension on ice. Resuspend the cell pellet in 1 mL PBS + 1% BSA and place the cell suspension on ice. 2.Predetermination of eosinophil cell count and rate.a.Dilute 10 μL of cell suspension with 40 μL PBS.b.On a Beckman Cytoflex S, eosinophil autofluorescence is best detected at 405/450 nm and 405/525 nm, e.g., corresponding to the PB450/VioBlue or KO525/VioGreen channels. Set the eosinophil autofluorescence gate according to Figure 1.Figure 1Determining eosinophil percentage after the lysis stepRepresentative dot plot showing unsorted cells after the lysis step on eosinophil autofluorescence-specific wave lengths of 405/450 nm and 405/525 nm. The gate for eosinophils was set on according to the positively separated cell population. Percentage and total cell count were used for the calculation of dilution with MACSQuant Tyto Running Buffer. Predetermination of eosinophil cell count and rate.a.Dilute 10 μL of cell suspension with 40 μL PBS.b.On a Beckman Cytoflex S, eosinophil autofluorescence is best detected at 405/450 nm and 405/525 nm, e.g., corresponding to the PB450/VioBlue or KO525/VioGreen channels. Set the eosinophil autofluorescence gate according to Figure 1.Figure 1Determining eosinophil percentage after the lysis stepRepresentative dot plot showing unsorted cells after the lysis step on eosinophil autofluorescence-specific wave lengths of 405/450 nm and 405/525 nm. The gate for eosinophils was set on according to the positively separated cell population. Percentage and total cell count were used for the calculation of dilution with MACSQuant Tyto Running Buffer. a.Dilute 10 μL of cell suspension with 40 μL PBS. Dilute 10 μL of cell suspension with 40 μL PBS. b.On a Beckman Cytoflex S, eosinophil autofluorescence is best detected at 405/450 nm and 405/525 nm, e.g., corresponding to the PB450/VioBlue or KO525/VioGreen channels. Set the eosinophil autofluorescence gate according to Figure 1.Figure 1Determining eosinophil percentage after the lysis stepRepresentative dot plot showing unsorted cells after the lysis step on eosinophil autofluorescence-specific wave lengths of 405/450 nm and 405/525 nm. The gate for eosinophils was set on according to the positively separated cell population. Percentage and total cell count were used for the calculation of dilution with MACSQuant Tyto Running Buffer. On a Beckman Cytoflex S, eosinophil autofluorescence is best detected at 405/450 nm and 405/525 nm, e.g., corresponding to the PB450/VioBlue or KO525/VioGreen channels. Set the eosinophil autofluorescence gate according to Figure 1.Figure 1Determining eosinophil percentage after the lysis stepRepresentative dot plot showing unsorted cells after the lysis step on eosinophil autofluorescence-specific wave lengths of 405/450 nm and 405/525 nm. The gate for eosinophils was set on according to the positively separated cell population. Percentage and total cell count were used for the calculation of dilution with MACSQuant Tyto Running Buffer. Determining eosinophil percentage after the lysis step Representative dot plot showing unsorted cells after the lysis step on eosinophil autofluorescence-specific wave lengths of 405/450 nm and 405/525 nm. The gate for eosinophils was set on according to the positively separated cell population. Percentage and total cell count were used for the calculation of dilution with MACSQuant Tyto Running Buffer. CRITICAL: We used a Cytoflex S (Beckman Coulter) flow cytometer for cell counting. When using other flow cytometry devices, please check the specific settings and use equivalent channels or channels detecting similar wave lengths. 3.Loading cells into the sorting chamber.a.To prime the cartridge, place it on the MACS Quant Tyto Priming Fixture by aligning the feet with the slots in the base (Figure 2).Figure 2Set-up for cartridge primingThe cartridge is placed on the dark green magnetic priming fixture in order to open the sort valve. A Syringe is screwed onto the input chamber. A Pre-Separation Filter (20 μm; green) is used for the following addition of the cell suspension.b.Open the intake of the input chamber (chamber with the depiction of an owl).c.Attach a syringe of which the plunger has been removed, onto it (Figure 2).d.Add 300 μL PBS + 1% BSA into the syringe.e.Insert the plunger and slowly and carefully push it down until PBS becomes visible in the positive collection chamber (middle chamber) and stop immediately. Troubleshooting 1.f.Remove the cartridge from the MACS Quant Tyto Priming Fixture and close the pressure inlet with the O-ring, which is located at the right corner underneath the cartridge, using your thumb.g.Continue pressing the plunger down until PBS becomes visible in the negative collection chamber. Stop immediately and remove the syringe.CRITICAL: Do not touch the microchip underneath the cartridge at any time. Troubleshooting 2.h.Place the cartridge in its plastic packaging on ice and remove the syringe.i.Dilute the 1 mL cell suspension in the appropriate calculated amount of Tyto Running Buffer and mix gently.CRITICAL: Adjust the cell concentration to a maximum of 2.1 × 106 total cells per mL sorting volume with an eosinophil rate between 0.8% and 8.2%.CRITICAL: Be aware of the maximum sorting volume of 10 mL per sort. A higher volume and dilution of the cell suspension will result in a longer duration of sort but also in higher purities. The maximum predicted eosinophil count must not exceed 1 × 106 cells/mL in the final sorting volume.j.Attach a syringe without the plunger onto the intake of the input chamber, place a green 20 μm pre-separation filter (Figure 2) on the syringe and filter the entire cell suspension.Note: If the cell suspension does not flow through the filter automatically, place a thumb flat on the intake of the filter and apply some air pressure onto the filter without touching the cell suspension. Alternatively, the filter can be moisturized with Tyto running buffer before usage.k.Remove the pre-separation filter, carefully insert the plunger into the syringe, and transfer the cell suspension into the input chamber.l.Remove the syringe and close the intake of the input chamber. Loading cells into the sorting chamber.a.To prime the cartridge, place it on the MACS Quant Tyto Priming Fixture by aligning the feet with the slots in the base (Figure 2).Figure 2Set-up for cartridge primingThe cartridge is placed on the dark green magnetic priming fixture in order to open the sort valve. A Syringe is screwed onto the input chamber. A Pre-Separation Filter (20 μm; green) is used for the following addition of the cell suspension.b.Open the intake of the input chamber (chamber with the depiction of an owl).c.Attach a syringe of which the plunger has been removed, onto it (Figure 2).d.Add 300 μL PBS + 1% BSA into the syringe.e.Insert the plunger and slowly and carefully push it down until PBS becomes visible in the positive collection chamber (middle chamber) and stop immediately. Troubleshooting 1.f.Remove the cartridge from the MACS Quant Tyto Priming Fixture and close the pressure inlet with the O-ring, which is located at the right corner underneath the cartridge, using your thumb.g.Continue pressing the plunger down until PBS becomes visible in the negative collection chamber. Stop immediately and remove the syringe.CRITICAL: Do not touch the microchip underneath the cartridge at any time. Troubleshooting 2.h.Place the cartridge in its plastic packaging on ice and remove the syringe.i.Dilute the 1 mL cell suspension in the appropriate calculated amount of Tyto Running Buffer and mix gently.CRITICAL: Adjust the cell concentration to a maximum of 2.1 × 106 total cells per mL sorting volume with an eosinophil rate between 0.8% and 8.2%.CRITICAL: Be aware of the maximum sorting volume of 10 mL per sort. A higher volume and dilution of the cell suspension will result in a longer duration of sort but also in higher purities. The maximum predicted eosinophil count must not exceed 1 × 106 cells/mL in the final sorting volume.j.Attach a syringe without the plunger onto the intake of the input chamber, place a green 20 μm pre-separation filter (Figure 2) on the syringe and filter the entire cell suspension.Note: If the cell suspension does not flow through the filter automatically, place a thumb flat on the intake of the filter and apply some air pressure onto the filter without touching the cell suspension. Alternatively, the filter can be moisturized with Tyto running buffer before usage.k.Remove the pre-separation filter, carefully insert the plunger into the syringe, and transfer the cell suspension into the input chamber.l.Remove the syringe and close the intake of the input chamber. a.To prime the cartridge, place it on the MACS Quant Tyto Priming Fixture by aligning the feet with the slots in the base (Figure 2).Figure 2Set-up for cartridge primingThe cartridge is placed on the dark green magnetic priming fixture in order to open the sort valve. A Syringe is screwed onto the input chamber. A Pre-Separation Filter (20 μm; green) is used for the following addition of the cell suspension. To prime the cartridge, place it on the MACS Quant Tyto Priming Fixture by aligning the feet with the slots in the base (Figure 2).Figure 2Set-up for cartridge primingThe cartridge is placed on the dark green magnetic priming fixture in order to open the sort valve. A Syringe is screwed onto the input chamber. A Pre-Separation Filter (20 μm; green) is used for the following addition of the cell suspension. Set-up for cartridge priming The cartridge is placed on the dark green magnetic priming fixture in order to open the sort valve. A Syringe is screwed onto the input chamber. A Pre-Separation Filter (20 μm; green) is used for the following addition of the cell suspension. b.Open the intake of the input chamber (chamber with the depiction of an owl). Open the intake of the input chamber (chamber with the depiction of an owl). c.Attach a syringe of which the plunger has been removed, onto it (Figure 2). Attach a syringe of which the plunger has been removed, onto it (Figure 2). d.Add 300 μL PBS + 1% BSA into the syringe. Add 300 μL PBS + 1% BSA into the syringe. e.Insert the plunger and slowly and carefully push it down until PBS becomes visible in the positive collection chamber (middle chamber) and stop immediately. Troubleshooting 1. Insert the plunger and slowly and carefully push it down until PBS becomes visible in the positive collection chamber (middle chamber) and stop immediately. Troubleshooting 1. f.Remove the cartridge from the MACS Quant Tyto Priming Fixture and close the pressure inlet with the O-ring, which is located at the right corner underneath the cartridge, using your thumb. Remove the cartridge from the MACS Quant Tyto Priming Fixture and close the pressure inlet with the O-ring, which is located at the right corner underneath the cartridge, using your thumb. g.Continue pressing the plunger down until PBS becomes visible in the negative collection chamber. Stop immediately and remove the syringe.CRITICAL: Do not touch the microchip underneath the cartridge at any time. Troubleshooting 2. Continue pressing the plunger down until PBS becomes visible in the negative collection chamber. Stop immediately and remove the syringe.CRITICAL: Do not touch the microchip underneath the cartridge at any time. Troubleshooting 2. CRITICAL: Do not touch the microchip underneath the cartridge at any time. Troubleshooting 2. h.Place the cartridge in its plastic packaging on ice and remove the syringe. Place the cartridge in its plastic packaging on ice and remove the syringe. i.Dilute the 1 mL cell suspension in the appropriate calculated amount of Tyto Running Buffer and mix gently.CRITICAL: Adjust the cell concentration to a maximum of 2.1 × 106 total cells per mL sorting volume with an eosinophil rate between 0.8% and 8.2%.CRITICAL: Be aware of the maximum sorting volume of 10 mL per sort. A higher volume and dilution of the cell suspension will result in a longer duration of sort but also in higher purities. The maximum predicted eosinophil count must not exceed 1 × 106 cells/mL in the final sorting volume. Dilute the 1 mL cell suspension in the appropriate calculated amount of Tyto Running Buffer and mix gently.CRITICAL: Adjust the cell concentration to a maximum of 2.1 × 106 total cells per mL sorting volume with an eosinophil rate between 0.8% and 8.2%.CRITICAL: Be aware of the maximum sorting volume of 10 mL per sort. A higher volume and dilution of the cell suspension will result in a longer duration of sort but also in higher purities. The maximum predicted eosinophil count must not exceed 1 × 106 cells/mL in the final sorting volume. CRITICAL: Adjust the cell concentration to a maximum of 2.1 × 106 total cells per mL sorting volume with an eosinophil rate between 0.8% and 8.2%. CRITICAL: Be aware of the maximum sorting volume of 10 mL per sort. A higher volume and dilution of the cell suspension will result in a longer duration of sort but also in higher purities. The maximum predicted eosinophil count must not exceed 1 × 106 cells/mL in the final sorting volume. j.Attach a syringe without the plunger onto the intake of the input chamber, place a green 20 μm pre-separation filter (Figure 2) on the syringe and filter the entire cell suspension.Note: If the cell suspension does not flow through the filter automatically, place a thumb flat on the intake of the filter and apply some air pressure onto the filter without touching the cell suspension. Alternatively, the filter can be moisturized with Tyto running buffer before usage. Attach a syringe without the plunger onto the intake of the input chamber, place a green 20 μm pre-separation filter (Figure 2) on the syringe and filter the entire cell suspension.Note: If the cell suspension does not flow through the filter automatically, place a thumb flat on the intake of the filter and apply some air pressure onto the filter without touching the cell suspension. Alternatively, the filter can be moisturized with Tyto running buffer before usage. Note: If the cell suspension does not flow through the filter automatically, place a thumb flat on the intake of the filter and apply some air pressure onto the filter without touching the cell suspension. Alternatively, the filter can be moisturized with Tyto running buffer before usage. k.Remove the pre-separation filter, carefully insert the plunger into the syringe, and transfer the cell suspension into the input chamber. Remove the pre-separation filter, carefully insert the plunger into the syringe, and transfer the cell suspension into the input chamber. l.Remove the syringe and close the intake of the input chamber. Remove the syringe and close the intake of the input chamber. 4.Eosinophil sort on MACSQuant Tyto.a.Scan the 2D barcode of the cartridge at the front of the MACS Quant Tyto Cell Sorter.b.Open the lid of the instrument and insert the cartridge in the correct orientation (with the input chamber facing the user and front of the instrument). The cartridge is placed correctly if the propeller in the input chamber starts spinning.c.In the user interface, select the cartridge type and enter the sample name and total sorting volume.d.Configure the live dot plot by selecting the channels CFP/VioBlue-H on the Y-axis and VioGreen-H on the X-axis.e.Start the cell flow in the cartridge by clicking the Play button in the lower right corner.f.Set a gate on the separated eosinophils population according to Figure 3 and select this gate as the sorting gate.Figure 3Eosinophil sorting using the MACSQuant Tyto Cell SorterRepresentative dot plot of eosinophil sorting with sort gate (P1) on the eosinophil population.g.Start sorting by pressing the Sort button in the lower right corner.CRITICAL: An abortion rate below 1% will result in a high yield and purity. If the abortion rate is higher, verify the purity of sorted eosinophils in order to ensure precise and effective sorting. If eosinophil purity and yield are inadequate, further dilute the cell suspension in the input chamber with Tyto running buffer.h.Stop the sort once all cells have been sorted or the desired number of sorted eosinophils has been acquired. Troubleshooting 3.i.Open the sort chamber and transfer the sorted eosinophils to a 1.5 mL microcentrifuge tube with a gel-loading tip.CRITICAL: Measure the exact volume with the pipette for subsequent calculations of eosinophil concentrations.j.Remove any remaining eosinophils from the sort chamber by washing it with 100 μL PBS. Collect the washing solution in the microcentrifuge tube and repeat this washing step twice. Keep eosinophils on ice.k.The eosinophils are now ready to be used in further experiments. Eosinophil sort on MACSQuant Tyto.a.Scan the 2D barcode of the cartridge at the front of the MACS Quant Tyto Cell Sorter.b.Open the lid of the instrument and insert the cartridge in the correct orientation (with the input chamber facing the user and front of the instrument). The cartridge is placed correctly if the propeller in the input chamber starts spinning.c.In the user interface, select the cartridge type and enter the sample name and total sorting volume.d.Configure the live dot plot by selecting the channels CFP/VioBlue-H on the Y-axis and VioGreen-H on the X-axis.e.Start the cell flow in the cartridge by clicking the Play button in the lower right corner.f.Set a gate on the separated eosinophils population according to Figure 3 and select this gate as the sorting gate.Figure 3Eosinophil sorting using the MACSQuant Tyto Cell SorterRepresentative dot plot of eosinophil sorting with sort gate (P1) on the eosinophil population.g.Start sorting by pressing the Sort button in the lower right corner.CRITICAL: An abortion rate below 1% will result in a high yield and purity. If the abortion rate is higher, verify the purity of sorted eosinophils in order to ensure precise and effective sorting. If eosinophil purity and yield are inadequate, further dilute the cell suspension in the input chamber with Tyto running buffer.h.Stop the sort once all cells have been sorted or the desired number of sorted eosinophils has been acquired. Troubleshooting 3.i.Open the sort chamber and transfer the sorted eosinophils to a 1.5 mL microcentrifuge tube with a gel-loading tip.CRITICAL: Measure the exact volume with the pipette for subsequent calculations of eosinophil concentrations.j.Remove any remaining eosinophils from the sort chamber by washing it with 100 μL PBS. Collect the washing solution in the microcentrifuge tube and repeat this washing step twice. Keep eosinophils on ice.k.The eosinophils are now ready to be used in further experiments. a.Scan the 2D barcode of the cartridge at the front of the MACS Quant Tyto Cell Sorter. Scan the 2D barcode of the cartridge at the front of the MACS Quant Tyto Cell Sorter. b.Open the lid of the instrument and insert the cartridge in the correct orientation (with the input chamber facing the user and front of the instrument). The cartridge is placed correctly if the propeller in the input chamber starts spinning. Open the lid of the instrument and insert the cartridge in the correct orientation (with the input chamber facing the user and front of the instrument). The cartridge is placed correctly if the propeller in the input chamber starts spinning. c.In the user interface, select the cartridge type and enter the sample name and total sorting volume. In the user interface, select the cartridge type and enter the sample name and total sorting volume. d.Configure the live dot plot by selecting the channels CFP/VioBlue-H on the Y-axis and VioGreen-H on the X-axis. Configure the live dot plot by selecting the channels CFP/VioBlue-H on the Y-axis and VioGreen-H on the X-axis. e.Start the cell flow in the cartridge by clicking the Play button in the lower right corner. Start the cell flow in the cartridge by clicking the Play button in the lower right corner. f.Set a gate on the separated eosinophils population according to Figure 3 and select this gate as the sorting gate.Figure 3Eosinophil sorting using the MACSQuant Tyto Cell SorterRepresentative dot plot of eosinophil sorting with sort gate (P1) on the eosinophil population. Set a gate on the separated eosinophils population according to Figure 3 and select this gate as the sorting gate.Figure 3Eosinophil sorting using the MACSQuant Tyto Cell SorterRepresentative dot plot of eosinophil sorting with sort gate (P1) on the eosinophil population. Eosinophil sorting using the MACSQuant Tyto Cell Sorter Representative dot plot of eosinophil sorting with sort gate (P1) on the eosinophil population. g.Start sorting by pressing the Sort button in the lower right corner.CRITICAL: An abortion rate below 1% will result in a high yield and purity. If the abortion rate is higher, verify the purity of sorted eosinophils in order to ensure precise and effective sorting. If eosinophil purity and yield are inadequate, further dilute the cell suspension in the input chamber with Tyto running buffer. Start sorting by pressing the Sort button in the lower right corner.CRITICAL: An abortion rate below 1% will result in a high yield and purity. If the abortion rate is higher, verify the purity of sorted eosinophils in order to ensure precise and effective sorting. If eosinophil purity and yield are inadequate, further dilute the cell suspension in the input chamber with Tyto running buffer. CRITICAL: An abortion rate below 1% will result in a high yield and purity. If the abortion rate is higher, verify the purity of sorted eosinophils in order to ensure precise and effective sorting. If eosinophil purity and yield are inadequate, further dilute the cell suspension in the input chamber with Tyto running buffer. h.Stop the sort once all cells have been sorted or the desired number of sorted eosinophils has been acquired. Troubleshooting 3. Stop the sort once all cells have been sorted or the desired number of sorted eosinophils has been acquired. Troubleshooting 3. i.Open the sort chamber and transfer the sorted eosinophils to a 1.5 mL microcentrifuge tube with a gel-loading tip.CRITICAL: Measure the exact volume with the pipette for subsequent calculations of eosinophil concentrations. Open the sort chamber and transfer the sorted eosinophils to a 1.5 mL microcentrifuge tube with a gel-loading tip.CRITICAL: Measure the exact volume with the pipette for subsequent calculations of eosinophil concentrations. CRITICAL: Measure the exact volume with the pipette for subsequent calculations of eosinophil concentrations. j.Remove any remaining eosinophils from the sort chamber by washing it with 100 μL PBS. Collect the washing solution in the microcentrifuge tube and repeat this washing step twice. Keep eosinophils on ice. Remove any remaining eosinophils from the sort chamber by washing it with 100 μL PBS. Collect the washing solution in the microcentrifuge tube and repeat this washing step twice. Keep eosinophils on ice. k.The eosinophils are now ready to be used in further experiments. The eosinophils are now ready to be used in further experiments. Flow cytometry staining to assess eosinophil purity and viability Timing: 30 min Timing: 30 min This protocol describes the procedure to analyze eosinophil purity and viability, as calculated from the total number of cells within the sorted fraction, using the eosinophil-specific marker Siglec-8 and DNA-intercalating 7-AAD.5.Transfer the appropriate volume containing 50,000 sorted eosinophils to a new microcentrifuge tube and centrifuge for 7 min at 350 × g and 4°C.6.Carefully discard the supernatants without disturbing the cell pellet.Note: Eosinophil pellets might not be visible to the naked eye. Pay attention to the orientation of the microcentrifuge tube in the centrifuge to identify the location of the pellet.7.Resuspend the eosinophil pellets with 100 μL PBS and mix thoroughly by pipetting.8.Transfer 50 μL into each of two new 1.5 mL microcentrifuge tubes.9.Add 1 μL of PC7 conjugated anti-Siglec-8 to one of the tubes and mix thoroughly by pipetting.CRITICAL: If antibodies from other manufacturers are used, it may be necessary to adjust the volume. Thus, we recommend using the antibody listed above.10.Add 1 μL of 7-AAD staining solution to the other tube and mix gently by pipetting.CRITICAL: A fluorescence minus one (FMO) control should be included to set the gates for marker positive or negative cells. For this purpose, measure without staining for Siglec-8 or 7-AAD in the FMO samples to identify Siglec-8 and 7-AAD negative populations in the flow cytometry dot plot.11.Incubate both tubes in the dark at 19°C–22°C for 10 min.12.Dilute both of the stained cell suspensions with 200 μL PBS.13.Proceed with flow cytometry analysis by measuring the PC7 (Siglec-8) and PC5.5 (7-AAD) fluorescence signals. Troubleshooting 3 and 4. 5.Transfer the appropriate volume containing 50,000 sorted eosinophils to a new microcentrifuge tube and centrifuge for 7 min at 350 × g and 4°C. Transfer the appropriate volume containing 50,000 sorted eosinophils to a new microcentrifuge tube and centrifuge for 7 min at 350 × g and 4°C. 6.Carefully discard the supernatants without disturbing the cell pellet. Carefully discard the supernatants without disturbing the cell pellet. Note: Eosinophil pellets might not be visible to the naked eye. Pay attention to the orientation of the microcentrifuge tube in the centrifuge to identify the location of the pellet. 7.Resuspend the eosinophil pellets with 100 μL PBS and mix thoroughly by pipetting. Resuspend the eosinophil pellets with 100 μL PBS and mix thoroughly by pipetting. 8.Transfer 50 μL into each of two new 1.5 mL microcentrifuge tubes. Transfer 50 μL into each of two new 1.5 mL microcentrifuge tubes. 9.Add 1 μL of PC7 conjugated anti-Siglec-8 to one of the tubes and mix thoroughly by pipetting. Add 1 μL of PC7 conjugated anti-Siglec-8 to one of the tubes and mix thoroughly by pipetting. CRITICAL: If antibodies from other manufacturers are used, it may be necessary to adjust the volume. Thus, we recommend using the antibody listed above. 10.Add 1 μL of 7-AAD staining solution to the other tube and mix gently by pipetting. Add 1 μL of 7-AAD staining solution to the other tube and mix gently by pipetting. CRITICAL: A fluorescence minus one (FMO) control should be included to set the gates for marker positive or negative cells. For this purpose, measure without staining for Siglec-8 or 7-AAD in the FMO samples to identify Siglec-8 and 7-AAD negative populations in the flow cytometry dot plot. 11.Incubate both tubes in the dark at 19°C–22°C for 10 min. Incubate both tubes in the dark at 19°C–22°C for 10 min. 12.Dilute both of the stained cell suspensions with 200 μL PBS. Dilute both of the stained cell suspensions with 200 μL PBS. 13.Proceed with flow cytometry analysis by measuring the PC7 (Siglec-8) and PC5.5 (7-AAD) fluorescence signals. Troubleshooting 3 and 4. Proceed with flow cytometry analysis by measuring the PC7 (Siglec-8) and PC5.5 (7-AAD) fluorescence signals. Troubleshooting 3 and 4. Giemsa staining Timing: 1.5 h Timing: 1.5 h This protocol describes the staining technique for distinguishing various cell types. It can also be used to visually assess the purity of isolated human eosinophils in cytospins. The characteristic bilobed nuclei will appear violet, and the granules will appear red. We recently described this protocol for basophils.614.Preparing the cytospins.a.Centrifuge 50,000 purified eosinophils per slide for 7 min at 350 × g.b.Resuspend the eosinophil pellet with 50 μL PBS.c.Place the filter card between the microscopy slide and the sample chamber so that the hole in the card aligns with the opening of the funnel.d.Secure the construction with a cytoclip, and place it into the cytocentrifuge.e.Transfer 50 μL of eosinophil suspension into the funnel of the sample chamber.f.Centrifuge for 5 min at 500 × g, at 19°C–22°C.g.Remove the sample chambers from the cytocentrifuge and remove the slides from the setup.h.Let the slides dry for 10 min.Pause point: Store cytospins at −20°C.i.Place cytospins into a methanol-filled glass staining trough and fix slides for 5 min.CRITICAL: Due to the toxicity of methanol, we recommend performing this step under a fume hood.j.Allow slides to air dry.15.Staining cytospins.a.Surround the spot where eosinophils are concentrated on the slides with a hydrophobic barrier pen and briefly air dry.b.Place cytospins slides on a flat surface.c.Pipette 200 μL diluted Giemsa staining solution onto the eosinophil spot.Note: The Giemsa staining solutions should sit on top of the slide in a domed fashion but not overflow over the hydrophobic barrier. It might be necessary to adjust the volume according to the size of the hydrophobic barrier.d.Incubate at 19°C–22°C for 20 min.e.Wash twice in staining buffer for 1 min each in a staining trough.f.Let slides air dry.g.Mount slides with 50 μL mounting medium and cover with coverslips.h.Let the slides air under the fume hood before starting microscopy analysis. 14.Preparing the cytospins.a.Centrifuge 50,000 purified eosinophils per slide for 7 min at 350 × g.b.Resuspend the eosinophil pellet with 50 μL PBS.c.Place the filter card between the microscopy slide and the sample chamber so that the hole in the card aligns with the opening of the funnel.d.Secure the construction with a cytoclip, and place it into the cytocentrifuge.e.Transfer 50 μL of eosinophil suspension into the funnel of the sample chamber.f.Centrifuge for 5 min at 500 × g, at 19°C–22°C.g.Remove the sample chambers from the cytocentrifuge and remove the slides from the setup.h.Let the slides dry for 10 min.Pause point: Store cytospins at −20°C.i.Place cytospins into a methanol-filled glass staining trough and fix slides for 5 min.CRITICAL: Due to the toxicity of methanol, we recommend performing this step under a fume hood.j.Allow slides to air dry. Preparing the cytospins.a.Centrifuge 50,000 purified eosinophils per slide for 7 min at 350 × g.b.Resuspend the eosinophil pellet with 50 μL PBS.c.Place the filter card between the microscopy slide and the sample chamber so that the hole in the card aligns with the opening of the funnel.d.Secure the construction with a cytoclip, and place it into the cytocentrifuge.e.Transfer 50 μL of eosinophil suspension into the funnel of the sample chamber.f.Centrifuge for 5 min at 500 × g, at 19°C–22°C.g.Remove the sample chambers from the cytocentrifuge and remove the slides from the setup.h.Let the slides dry for 10 min.Pause point: Store cytospins at −20°C.i.Place cytospins into a methanol-filled glass staining trough and fix slides for 5 min.CRITICAL: Due to the toxicity of methanol, we recommend performing this step under a fume hood.j.Allow slides to air dry. a.Centrifuge 50,000 purified eosinophils per slide for 7 min at 350 × g. Centrifuge 50,000 purified eosinophils per slide for 7 min at 350 × g. b.Resuspend the eosinophil pellet with 50 μL PBS. Resuspend the eosinophil pellet with 50 μL PBS. c.Place the filter card between the microscopy slide and the sample chamber so that the hole in the card aligns with the opening of the funnel. Place the filter card between the microscopy slide and the sample chamber so that the hole in the card aligns with the opening of the funnel. d.Secure the construction with a cytoclip, and place it into the cytocentrifuge. Secure the construction with a cytoclip, and place it into the cytocentrifuge. e.Transfer 50 μL of eosinophil suspension into the funnel of the sample chamber. Transfer 50 μL of eosinophil suspension into the funnel of the sample chamber. f.Centrifuge for 5 min at 500 × g, at 19°C–22°C. Centrifuge for 5 min at 500 × g, at 19°C–22°C. g.Remove the sample chambers from the cytocentrifuge and remove the slides from the setup. Remove the sample chambers from the cytocentrifuge and remove the slides from the setup. h.Let the slides dry for 10 min.Pause point: Store cytospins at −20°C. Let the slides dry for 10 min.Pause point: Store cytospins at −20°C. Pause point: Store cytospins at −20°C. i.Place cytospins into a methanol-filled glass staining trough and fix slides for 5 min.CRITICAL: Due to the toxicity of methanol, we recommend performing this step under a fume hood. Place cytospins into a methanol-filled glass staining trough and fix slides for 5 min.CRITICAL: Due to the toxicity of methanol, we recommend performing this step under a fume hood. CRITICAL: Due to the toxicity of methanol, we recommend performing this step under a fume hood. j.Allow slides to air dry. Allow slides to air dry. 15.Staining cytospins.a.Surround the spot where eosinophils are concentrated on the slides with a hydrophobic barrier pen and briefly air dry.b.Place cytospins slides on a flat surface.c.Pipette 200 μL diluted Giemsa staining solution onto the eosinophil spot.Note: The Giemsa staining solutions should sit on top of the slide in a domed fashion but not overflow over the hydrophobic barrier. It might be necessary to adjust the volume according to the size of the hydrophobic barrier.d.Incubate at 19°C–22°C for 20 min.e.Wash twice in staining buffer for 1 min each in a staining trough.f.Let slides air dry.g.Mount slides with 50 μL mounting medium and cover with coverslips.h.Let the slides air under the fume hood before starting microscopy analysis. Staining cytospins.a.Surround the spot where eosinophils are concentrated on the slides with a hydrophobic barrier pen and briefly air dry.b.Place cytospins slides on a flat surface.c.Pipette 200 μL diluted Giemsa staining solution onto the eosinophil spot.Note: The Giemsa staining solutions should sit on top of the slide in a domed fashion but not overflow over the hydrophobic barrier. It might be necessary to adjust the volume according to the size of the hydrophobic barrier.d.Incubate at 19°C–22°C for 20 min.e.Wash twice in staining buffer for 1 min each in a staining trough.f.Let slides air dry.g.Mount slides with 50 μL mounting medium and cover with coverslips.h.Let the slides air under the fume hood before starting microscopy analysis. a.Surround the spot where eosinophils are concentrated on the slides with a hydrophobic barrier pen and briefly air dry. Surround the spot where eosinophils are concentrated on the slides with a hydrophobic barrier pen and briefly air dry. b.Place cytospins slides on a flat surface. Place cytospins slides on a flat surface. c.Pipette 200 μL diluted Giemsa staining solution onto the eosinophil spot.Note: The Giemsa staining solutions should sit on top of the slide in a domed fashion but not overflow over the hydrophobic barrier. It might be necessary to adjust the volume according to the size of the hydrophobic barrier. Pipette 200 μL diluted Giemsa staining solution onto the eosinophil spot.Note: The Giemsa staining solutions should sit on top of the slide in a domed fashion but not overflow over the hydrophobic barrier. It might be necessary to adjust the volume according to the size of the hydrophobic barrier. Note: The Giemsa staining solutions should sit on top of the slide in a domed fashion but not overflow over the hydrophobic barrier. It might be necessary to adjust the volume according to the size of the hydrophobic barrier. d.Incubate at 19°C–22°C for 20 min. Incubate at 19°C–22°C for 20 min. e.Wash twice in staining buffer for 1 min each in a staining trough. Wash twice in staining buffer for 1 min each in a staining trough. f.Let slides air dry. Let slides air dry. g.Mount slides with 50 μL mounting medium and cover with coverslips. Mount slides with 50 μL mounting medium and cover with coverslips. h.Let the slides air under the fume hood before starting microscopy analysis. Let the slides air under the fume hood before starting microscopy analysis. Flow cytometry staining to assess CD16 expression on eosinophils Timing: 30 min Timing: 30 min This section outlines the procedure for analyzing CD16 expression on eosinophils using flow cytometry. The goal is to emphasize the significance of including CD16+ eosinophils in subsequent experiments. Eosinophils are stained with a CD16 antibody after cell sorting.16.Centrifuge 50,000 sorted eosinophils for 7 min at 350 × g and 4°C in a microcentrifuge.17.Carefully discard the supernatants without disturbing the cell pellet.18.Resuspend the eosinophil pellets in 50 μL of PBS and mix thoroughly by pipetting.19.Add 1.5 μL CD16 antibody and mix thoroughly by pipetting.Optional: To ensure confident identification of eosinophils when the cells are not completely pure, the eosinophil-specific marker Siglec-8 could also be stained. For that, please keep in mind that the fluorophore-conjugation of the antibodies needs to be adjusted.20.Incubate cells for 10 min in the dark at 19°C–22°C.21.Before measurement, dilute the cell suspension with 200 μL of PBS and mix by pipetting.22.Proceed with flow cytometry analysis.Optional: If the percentage of CD16 expression is to be analyzed, include an FMO control in order to set the gate for marker positive eosinophils. For that measure eosinophils without staining of CD16 to see where CD16− eosinophils are located.Note: If exclusively CD16− or CD16+ eosinophils are required for further experiments, eosinophils can potentially be sorted according to their CD16 expression. Set up another sort and stain eosinophils with a CD16 antibody and adjust the sort gate to CD16− or CD16+ eosinophils. However, this procedure has not been tested and verified by us. 16.Centrifuge 50,000 sorted eosinophils for 7 min at 350 × g and 4°C in a microcentrifuge. Centrifuge 50,000 sorted eosinophils for 7 min at 350 × g and 4°C in a microcentrifuge. 17.Carefully discard the supernatants without disturbing the cell pellet. Carefully discard the supernatants without disturbing the cell pellet. 18.Resuspend the eosinophil pellets in 50 μL of PBS and mix thoroughly by pipetting. Resuspend the eosinophil pellets in 50 μL of PBS and mix thoroughly by pipetting. 19.Add 1.5 μL CD16 antibody and mix thoroughly by pipetting. Add 1.5 μL CD16 antibody and mix thoroughly by pipetting. Optional: To ensure confident identification of eosinophils when the cells are not completely pure, the eosinophil-specific marker Siglec-8 could also be stained. For that, please keep in mind that the fluorophore-conjugation of the antibodies needs to be adjusted. 20.Incubate cells for 10 min in the dark at 19°C–22°C. Incubate cells for 10 min in the dark at 19°C–22°C. 21.Before measurement, dilute the cell suspension with 200 μL of PBS and mix by pipetting. Before measurement, dilute the cell suspension with 200 μL of PBS and mix by pipetting. 22.Proceed with flow cytometry analysis. Proceed with flow cytometry analysis. Optional: If the percentage of CD16 expression is to be analyzed, include an FMO control in order to set the gate for marker positive eosinophils. For that measure eosinophils without staining of CD16 to see where CD16− eosinophils are located. Note: If exclusively CD16− or CD16+ eosinophils are required for further experiments, eosinophils can potentially be sorted according to their CD16 expression. Set up another sort and stain eosinophils with a CD16 antibody and adjust the sort gate to CD16− or CD16+ eosinophils. However, this procedure has not been tested and verified by us. Eosinophil activation test Timing: 1 day Timing: 1 day This section describes the procedure to measure the externalization of the eosinophil activation marker CD69 upon stimulation with the eosinophil activating cytokine IL-3.23.Centrifuge 100,000 eosinophils per condition in a microcentrifuge tube for 7 min and 350 × g at 19°C–22°C.24.Discard the supernatant and resuspend the eosinophil pellet in 90 μL of prewarmed, RPMI 1640 medium with 10% FBS and 1% Penicillin-Streptomycin, for each experimental condition (a total volume of 180 μL with 200,000 cells for two conditions, etc.).25.Use a 1.5 mL microcentrifuge tube per experimental condition and transfer 90 μL of the eosinophil suspension into each tube.26.Dilute IL-3 to a concentration of 100 ng/mL.27.Add 10 μL of the diluted IL-3 to achieve the final concentration of 10 ng/mL in the cell suspension, or RPMI medium for the negative control, and mix well by pipetting.28.Place the microcentrifuge tubes into a cell incubator and incubate for 21 h at 37°C and 5% CO2.CRITICAL: Do not close the lids of the microcentrifuge tubes completely when placing them into the incubator, but leave them slightly open. This allows CO2 to reach the eosinophils during incubation. V-bottom 96-well plates may be used as an alternative to microcentrifuge tubes if desired.29.Place the cells on ice for 2 min to stop cell activity.30.Centrifuge the cells for 7 min at 350 × g and 4°C in a microcentrifuge.31.Remove and discard the supernatants carefully without disturbing the pellet.32.Resuspend the eosinophil pellets with 50 μL PBS and mix well by pipetting.33.Add 1 μL APC-CD69 antibody and mix well by pipetting.Optional: For eosinophil identification, the eosinophil-specific marker Siglec-8 could also be stained when cells are not completely pure.34.Incubate cells for 10 min in the dark at 19°C–22°C.35.Before measurement, dilute the cell suspension with 200 μL of PBS and mix by pipetting.36.Proceed with flow cytometry analysis. Troubleshooting 5.Note: To determine cell activation, eosinophils were stained with a CD69 antibody. Marker expression can be either described as percentage of positive eosinophils, or as MFI (mean fluorescence intensity). MFI provides more accurate information about marker expression density on the cell surface, while percentages only give information about if eosinophils express the marker or not. 23.Centrifuge 100,000 eosinophils per condition in a microcentrifuge tube for 7 min and 350 × g at 19°C–22°C. Centrifuge 100,000 eosinophils per condition in a microcentrifuge tube for 7 min and 350 × g at 19°C–22°C. 24.Discard the supernatant and resuspend the eosinophil pellet in 90 μL of prewarmed, RPMI 1640 medium with 10% FBS and 1% Penicillin-Streptomycin, for each experimental condition (a total volume of 180 μL with 200,000 cells for two conditions, etc.). Discard the supernatant and resuspend the eosinophil pellet in 90 μL of prewarmed, RPMI 1640 medium with 10% FBS and 1% Penicillin-Streptomycin, for each experimental condition (a total volume of 180 μL with 200,000 cells for two conditions, etc.). 25.Use a 1.5 mL microcentrifuge tube per experimental condition and transfer 90 μL of the eosinophil suspension into each tube. Use a 1.5 mL microcentrifuge tube per experimental condition and transfer 90 μL of the eosinophil suspension into each tube. 26.Dilute IL-3 to a concentration of 100 ng/mL. Dilute IL-3 to a concentration of 100 ng/mL. 27.Add 10 μL of the diluted IL-3 to achieve the final concentration of 10 ng/mL in the cell suspension, or RPMI medium for the negative control, and mix well by pipetting. Add 10 μL of the diluted IL-3 to achieve the final concentration of 10 ng/mL in the cell suspension, or RPMI medium for the negative control, and mix well by pipetting. 28.Place the microcentrifuge tubes into a cell incubator and incubate for 21 h at 37°C and 5% CO2. Place the microcentrifuge tubes into a cell incubator and incubate for 21 h at 37°C and 5% CO2. CRITICAL: Do not close the lids of the microcentrifuge tubes completely when placing them into the incubator, but leave them slightly open. This allows CO2 to reach the eosinophils during incubation. V-bottom 96-well plates may be used as an alternative to microcentrifuge tubes if desired. 29.Place the cells on ice for 2 min to stop cell activity. Place the cells on ice for 2 min to stop cell activity. 30.Centrifuge the cells for 7 min at 350 × g and 4°C in a microcentrifuge. Centrifuge the cells for 7 min at 350 × g and 4°C in a microcentrifuge. 31.Remove and discard the supernatants carefully without disturbing the pellet. Remove and discard the supernatants carefully without disturbing the pellet. 32.Resuspend the eosinophil pellets with 50 μL PBS and mix well by pipetting. Resuspend the eosinophil pellets with 50 μL PBS and mix well by pipetting. 33.Add 1 μL APC-CD69 antibody and mix well by pipetting. Add 1 μL APC-CD69 antibody and mix well by pipetting. Optional: For eosinophil identification, the eosinophil-specific marker Siglec-8 could also be stained when cells are not completely pure. 34.Incubate cells for 10 min in the dark at 19°C–22°C. Incubate cells for 10 min in the dark at 19°C–22°C. 35.Before measurement, dilute the cell suspension with 200 μL of PBS and mix by pipetting. Before measurement, dilute the cell suspension with 200 μL of PBS and mix by pipetting. 36.Proceed with flow cytometry analysis. Troubleshooting 5. Proceed with flow cytometry analysis. Troubleshooting 5. Note: To determine cell activation, eosinophils were stained with a CD69 antibody. Marker expression can be either described as percentage of positive eosinophils, or as MFI (mean fluorescence intensity). MFI provides more accurate information about marker expression density on the cell surface, while percentages only give information about if eosinophils express the marker or not. Expected outcomes We achieved yields between 36,000 and 446,000 eosinophils (mean 252,000/mL) per mL EDTA blood (Figure 4A) with purities consistently exceeding 99% (mean 99.8%; ± 0.03% SEM) (Figure 4B) and a mean viability of 92.8% (± 1.01% SEM) (Figure 4C). The viability was determined by staining with the DNA-intercalating dye 7-AAD. A representative dot plot is shown in Figure 4D. The purity was determined by analyzing singlets and staining with the eosinophil-specific marker Siglec-8. The gate was set according to the fluorescence minus one control (FMO) Figure 4F. Representative dot plots are shown in Figure 4E. Additionally, we visualized eosinophil purity through a microscopic image after Giemsa staining (Figure 5).Figure 4Yield, purity and viability of isolated eosinophils(A) Eosinophil yield was calculated through the number of sorted events and the volume of EDTA blood that was utilized (n = 13; ± SEM).(B) Eosinophil purity was assessed by measuring the percentage of Siglec-8 positive cells through flow cytometry (n = 13; ± SEM).(C) Eosinophils viability was determined directly after purification through the exclusion of 7-AAD positive eosinophils (n = 11; ± SEM).(D) Representative dot plot showing the typical viability of eosinophils directly after purification by measuring the percentage of 7-AAD negative eosinophils.(E) Gating strategy to identify eosinophils through flow cytometry analysis in a representative sample. Side scatter (SSC-A) and forward scatter (FSC-A) properties for detecting eosinophil-sized cells after cell sorting. Eosinophils were identified after the exclusion of doublets through measuring Siglec-8 positive cells.(F) Overlay histogram of the fluorescence minus one (FMO) control and Siglec-8 stained eosinophils.Figure 5Giemsa staining of isolated human eosinophilsRepresentative bright field microscopy image of eosinophil cytospins at 60x magnification. Eosinophils can be identified by their bilobed nuclei and eosinophilic granules. Yield, purity and viability of isolated eosinophils (A) Eosinophil yield was calculated through the number of sorted events and the volume of EDTA blood that was utilized (n = 13; ± SEM). (B) Eosinophil purity was assessed by measuring the percentage of Siglec-8 positive cells through flow cytometry (n = 13; ± SEM). (C) Eosinophils viability was determined directly after purification through the exclusion of 7-AAD positive eosinophils (n = 11; ± SEM). (D) Representative dot plot showing the typical viability of eosinophils directly after purification by measuring the percentage of 7-AAD negative eosinophils. (E) Gating strategy to identify eosinophils through flow cytometry analysis in a representative sample. Side scatter (SSC-A) and forward scatter (FSC-A) properties for detecting eosinophil-sized cells after cell sorting. Eosinophils were identified after the exclusion of doublets through measuring Siglec-8 positive cells. (F) Overlay histogram of the fluorescence minus one (FMO) control and Siglec-8 stained eosinophils. Giemsa staining of isolated human eosinophils Representative bright field microscopy image of eosinophil cytospins at 60x magnification. Eosinophils can be identified by their bilobed nuclei and eosinophilic granules. Unlike conventional methods, this novel approach also isolates eosinophils that are CD16+. Therefore, we determined its expression through flow cytometry analysis utilizing a CD16 antibody. We found that CD16 is expressed on the cell surface of 14% (± 1.28% SEM) of isolated eosinophils which varies between donors (Figure 6A, n = 13). Analyzing CD16+ eosinophils can be crucial when investigating eosinophils in health and disease. For instance, CD16 expression is associated with atopy.3 Figure 6B shows a representative dot plot of n = 13 different samples of CD16 expression on purified eosinophils.Figure 6CD16 expression on freshly purified human eosinophils(A) Percentage of CD16− and CD16+ eosinophils directly after isolation determined using flow cytometry (n = 13; ± SEM).(B) Representative dot plot demonstrating typical CD16 expression on eosinophils after purification. CD16 expression on freshly purified human eosinophils (A) Percentage of CD16− and CD16+ eosinophils directly after isolation determined using flow cytometry (n = 13; ± SEM). (B) Representative dot plot demonstrating typical CD16 expression on eosinophils after purification. It is critical that eosinophils are not activated during the cell sorting procedure. We therefore conducted a subsequent eosinophil activation test in order to assess their responsiveness to external stimuli. Purified eosinophils were stimulated with IL-3 (10 ng/mL) for 21 h and the surface externalization of the activation marker CD69 was measured. Sorted eosinophils showed low levels of activation which then could be significantly induced by IL-3 (p = 0.0003) (Figure 7A). The representative histogram illustrates the shift of CD69 MFI after IL-3 stimulation compared to the negative control and antibody isotype control (Figure 7B). A potential future application of this sorting technique might also be label-free separation of activated eosinophils from non-activated eosinophils through autofluorescence of NADH and NADPH, which is synthetized during cell activation.Figure 7Eosinophil activation testFlow cytometry analysis of CD69 protein externalization after stimulation with IL-3. Eosinophils were stimulated with RPMI medium (Co) or IL-3 (10 ng/mL) for 21 h (n = 7).(A) CD69 surface content is significantly increased after stimulation with IL-3. Data shown as mean ± SEM, p-values (∗∗∗ ≤ 0.001). Significance is calculated in relation to the Co group.(B) Representative histogram of CD69 MFI of IL-3-stimulated eosinophils, unstimulated eosinophils (control), and CD69 antibody isotype control. Eosinophil activation test Flow cytometry analysis of CD69 protein externalization after stimulation with IL-3. Eosinophils were stimulated with RPMI medium (Co) or IL-3 (10 ng/mL) for 21 h (n = 7). (A) CD69 surface content is significantly increased after stimulation with IL-3. Data shown as mean ± SEM, p-values (∗∗∗ ≤ 0.001). Significance is calculated in relation to the Co group. (B) Representative histogram of CD69 MFI of IL-3-stimulated eosinophils, unstimulated eosinophils (control), and CD69 antibody isotype control. Quantification and statistical analysis Flow cytometry data were analyzed with the Kaluza software (Beckman Coulter) and GraphPad Prism. A paired t test was used for statistical analysis. Limitations When performing this method to purify very high numbers of eosinophils, the yield can be a limiting factor. This limitation arises from natural variations in blood donors, limited sort volume and limited number of cells in suspension that can be sorted precisely. More EDTA blood could be used for purification as long as the abortion rate remains < 1%. Otherwise, a second run on the cell sorter is recommended after all chambers have been emptied and reapplying fresh cell suspension in the input chamber. Troubleshooting Problem 1 The cartridge has a leak at the bottom and loses liquid during priming, loading, or after starting the sort. Potential solution For priming and loading the cartridge, it is crucial to press the plunger of the syringe slowly and gently. Otherwise the pressure might be too high causing a little crack at the bottom of the cartridge which is often invisible until the sort is started. If a leak is detected after starting the sort, stop the process, remove the cartridge from MACSQuant Tyto Cell Sorter and clean the lens carefully with a dustless paper towel and ethanol. Afterwards, transfer the cell suspension to the input chamber of a new and primed cartridge and restart the sort. Problem 2 The cell sorter fails to locate the correct position of the cartridge and stops the process. Potential solution Ensure that the microchip beneath the cartridge remains untouched until sorting begins, and avoid condensation on the cartridge. Any contamination or residue can affect the localization of the correct position. If this occurs, try removing and reinserting the cartridge. If the issue persists, replace the cartridge with a new one. Problem 3 The eosinophil purity or yield is poor. Potential solution The cell density may be too high for a precise sorting which could result in poor purity. If the abortion rate exceeds 1% during sorting, the cell sorter is not able to isolate all eosinophils effectively. In this case further dilute the cell suspension in the input chamber and restart the sort. Furthermore, ensure that as much supernatant as possible is decanted after the lysis step to minimize debris. Additionally, keep in mind that the numbers of eosinophils vary between donors, even within the same donor on different days. In some rare instances, a donor may have complete eosinopenia, making it impossible to isolate eosinophils from their blood samples. Problem 4 Eosinophils show poor viability after cell sorting. Potential solution Eosinophils have a relatively short life span of around 18 h in peripheral blood. Thus, blood samples should be cooled and processed within a few hours after collection. We typically always start this protocol within 4 h after blood donation as we have observed that the viability drops to around 80% after 24 h, even when being cooled throughout. After the lysis step the cells should be kept on ice until the sort is started. To ensure low temperatures during the sort, turn on the cell sorter at least half an hour before sorting, as the device needs time to cool down to 4°C. Buffy coats may also be used as a source for eosinophils as we have observed that the viability remains above 90%, even after 24 h in preliminary tests. Problem 5 Eosinophils are already activated directly after isolation or in the negative control of the eosinophil activation test. Potential solution The activation status of eosinophils after sorting can strongly differ between different blood donors due to prior contact with substances that the donors might be allergic to. Therefore, CD69 externalization can be increased directly after cell sorting or in the negative control. We recommend performing the eosinophil activation test with blood drawn before exposure to allergens, or with blood from non-atopic donors. Resource availability Lead contact Ulrike Raap (raap.ulrike@klinikum-oldenburg.de). Technical contact Tobias Weihrauch (tobias.weihrauch@uni-oldenburg.de). Materials availability This study did not generate new unique reagents. Data and code availability The published article includes all data generated or analyzed during this study. Acknowledgments This work was supported by the German Research Foundation DFG with a grant to U.R. (RA-1026/3-2) (FOR2690-PruSEARCH Translational Pruritus Research). We would like to thank A. Marten and I. Kerkhoff for providing excellent technical support. We also appreciate the assistance of the cell sorting facility supported by the DFG (ID424196510). Furthermore, we thank C. Müller, T. Müller, T. Schricker, K. Schmidt, A. Heineke, N. Windeler, R. Kluck, L. Fieber, I. Latoschinski, and K. Ubber for collecting blood samples from the donors. The authors also thank Arne Knörk from Miltenyi Biotec for sharing his expertise on cell sorting. Author contributions T.W.: conceptualization, data analysis, investigation, methodology, validation, visualization, and writing – original draft. N.G.: investigation, methodology, and writing – review and editing. N.H.M.: conceptualization, methodology, and writing – review and editing. K.L.: writing – review and editing. U.R.: conceptualization, funding acquisition, supervision, validation, and writing – review and editing. Declaration of interests The authors declare no competing interests.